002737: Sunflower Pharmaceutical Group Co., Ltd. - Summary | Jitta

Sunflower Pharmaceutical Group Co., Ltd.

CHN:002737

Price
CN¥13.51
Loss Chance
50.9%
3.36JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
245 / 486
2,404 / 5,270
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (29)
Recent Business Performance (31)
Financial Strength (64)
Return to Shareholders (30)
Competitive Advantage (38)
Jitta Signs
Debt LevelLow Long Term Debt
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 163.95% in the last year
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
3.36
100.00%
4.40
> 1,000%
4.23
> 1,000%
Pharmaceuticals
7.55
2.58%
5.63
16.32%
7.34
27.35%
COMPANY DESCRIPTION
Sunflower Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of Chinese medicines in China and internationally. It offers traditional Chinese medicines, chemical drugs, biological drugs, and health and wellness products, as well as adult and children’s medicines for various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold ailments, rheumatism and bone disease, cardiovascular and cerebrovascular diseases, and general health. The company is also involved in leasing and business services; scientific research and technical services; and wholesale and retail trade. It sells its products under the Sunflower and Little Sunflower brand names. The company was founded in 2005 and is headquartered in Harbin, China.